Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists

Related Content

ICD Guidelines From ACC/AHA/NASPE Embrace MADIT-II Prophylactic Use

Sep 30 2002

Guidant Expects Similar 20% Penetration Of Expanded ICD Market Via MADIT

Jan 14 2002

MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool

Feb 17 2003

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window